Overview

Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma

Status:
Suspended

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The aim of the study is to evaluate the feasibility defined as overall tolerance and toxicity as well as relative dose-intensity and cumulative dose delivered, of an association ofgemcitabine, oxaliplatin and radiotherapy in patients with locally advanced and unresectable, but non-metastatic pancreatic adenocarcinoma or cholangiocarcinoma

Phase:

Phase 2

Details

Lead Sponsor:

University Hospital, Ghent

Treatments:

Gemcitabine
Oxaliplatin